Completed

COVIT-EHPADCOvid-19 et VITamine d en EHPAD

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected from past medical records and data - Retrospective
Who is being recruted

Coronaviridae Infections+3

+ Infections

+ RNA Virus Infections

Over 70 Years
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: March 2020
See protocol details

Summary

Principal SponsorUniversity Hospital, Angers
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: March 15, 2020

Actual date on which the first participant was enrolled.

Retrospective observational unicentric study in nursing-home residents with COVID-19. Health status monitoring data available until May 15, 2020. For all participants, gender, age, disability, history and comorbidities, treatments, date of last vitamin D3 supplementation, results of last blood test, date of suspicion / diagnosis of COVID-19, COVID-19 OSCI score, and eventual hospitalization or death (surveillance data available until May 15, 2020) are collected.

Official TitleCOvid-19 et VITamine d en EHPAD
NCT04435119
Principal SponsorUniversity Hospital, Angers
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

96 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 70 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Coronaviridae InfectionsInfectionsRNA Virus InfectionsVirus DiseasesCoronavirus InfectionsNidovirales Infections

Criteria

Inclusion Criteria: * Living in the nursing-home of Saint Laurent-de-Chamousset, France, during the COVID-19 epidemic (March-April 2020) * Being suspected or diagnosed with COVID-19 (RT-PCR, chest CT scan) Exclusion Criteria: \- Opposition of the resident and/or relatives to the use of anonymized clinical-biological data

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Angers University Hospital

Angers, FranceOpen Angers University Hospital in Google Maps
CompletedOne Study Center
COVIT-EHPAD | COvid-19 et VITamine d en EHPAD | PatLynk